Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Bain Capital Private Equity in the transaction. Bain Capital Private Equity executed its acquisition, and related financing, of a majority stake in...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig represented Huadong Medicine on the deal, while Ropes & Gray advised Kiniksa Pharmaceuticals. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP advised Yonghe Medical on the deal. Yonghe Medical Group Co., Ltd. (2279.HK) announced its HK$1.49 billion (approximately US$192 million) initial public offering and...
You must be a Standard 1 Year member to access this content.
Zhong Lun and Ropes & Gray advised LianBio on the deal. LianBio executed an initial public offering and listing of American depositary shares on the Nasdaq...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised Morgan Stanley and CICC on the matter while O’Melveny & Myers and Maples and Calder represented Acotec Scientific Holdings Limited. The...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented an affiliate of Baring Private Equity Asia in the transaction, while Yigal Arnon & Co. and Latham & Watkins represented Boston Scientific,...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors. O’Melveny & Myers LLP and and Jingtian & Gongcheng advised...
You must be a Standard 1 Year member to access this content.
